In November, clinical trial platform developer Medable raised $91 million in private funding, amid the COVID-19 pandemic that touched off huge demand among pharmaceutical companies looking to initiate “siteless” or virtual clinical trials. These trials can offer several advantages for pharmaceutical companies, including the ability to recruit patients who can’t travel to physical sites to participate in research, become more cost-efficient and enable the enhanced use of telehealth in clinical trials. In this webinar, we’ll explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area.

Topics include:

• Best practices for choosing and providing user-friendly equipment that patients in clinical trials will need to participate in virtual trials.
• Overcoming operational challenges that can arise when patients participate in virtual trials, for example by using hybrid models that incorporate in-home visits from nurses and other clinicians.
• How to work with patients to ensure the security of data that’s transferred from wearables and other equipment used in their homes to clinical trial investigators.